Dr. Michael Hooman Moghimi, MD

Dr. Moghimi practices at Hyde Park Surgery Center in Austin, Texas.

Dr. Moghimi's NPI, 1063640001, was assigned on June 29, 2009. Dr. Moghimi graduated from McGovern Medical School in 2008. Dr. Moghimi holds Texas license BP10034232.

Dr. Moghimi's primary practice is Hyde Park Surgery Center, at 4611 Guadalupe Street, Ste 100, Austin, TX 78751. The practice phone is (512) 420-2303.

Dr. Moghimi's primary practice is Hyde Park Surgery Center in Austin, Texas. Dr. Moghimi is also affiliated with St. David's Medical Center. The medical group on file is Orthopaedic Specialists of Austin. Dmand AI also links Dr. Moghimi to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moghimi practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Moghimi's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Moghimi is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Moghimi's licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists arthritis, back and neck pain treatment without fusion, enthesopathy in arms, joint pain, lower back pain, neck pain and spine problems, rotator cuff injury and scoliosis among the conditions Dr. Moghimi treats.

CMS data shows 4,229 Medicare services from Dr. Moghimi across 27 procedure codes in 2024, for 676 Medicare patients. Medicare paid $403,221 for them.

CMS counts 676 Medicare patients who saw Dr. Moghimi in 2024. The largest group is 65 to 74, with 354 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moghimi's median patient age at 68, with 55% women.

In 2024, Dr. Moghimi wrote 749 Medicare Part D claims for 282 patients. 99% of them were for generic drugs. CMS names the drug for 653 of them, across 10 drugs with 11 or more claims each, at $6,389 in total drug cost. In 2023, CMS named 499 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Moghimi for performance year 2024, reported as part of a group. Dr. Moghimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moghimi as offering telehealth. CMS counts 326 procedures of spinal fusion by Dr. Moghimi, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Moghimi, published from 2014 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Lumbar Vertebrae, Postoperative Complications and Spinal Fusion. Dr. Moghimi has published most often in Spine J. Dr. Moghimi's most frequent co-authors are Christopher M. Bono, MD, Andrew J. Schoenfeld, MD and Amandeep Bhalla, MD.

Dmand AI links Dr. Moghimi to 1 clinical trial. Conditions studied include Spondylolisthesis and Spondylolysis.

CMS Open Payments shows 270 general payments to Dr. Moghimi from 34 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 57% of the total. Spineart SA paid the most, $68,875.

Dr. Moghimi graduated from McGovern Medical School in 2008. Dr. Moghimi is a member of AAOS, NASS and TMA.

Dr. Moghimi is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.